Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
| Autor: | Paridaens, R. *, Dirix, L., Lohrisch, C., Beex, L., Nooij, M., Cameron, D., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., Lobelle, J.P., Piccart, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2003 14(9):1391-1398 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|